FR EN

Back


11/09/2014
AM-Pharma Closes €12.2m Financing Round
AM-Pharma B.V. a biopharmaceutical company focused on the development of recAP (recombinant human Alkaline Phosphatase) for inflammatory indications announces that it has closed a €12.2 million financing round led by Gilde Healthcare. Existing investors AbbVie BB Biotech Ventures Idinvest Partners Inventages Kurma Biofund and Ysios Capital also participated in the round.




X

X

X